• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

pharmacy benefit manager (PBM)

Expion Health and Cost Plus Drugs Partner to Combat Soaring Specialty Drug Costs

by Jasmine Pennic 11/29/2023 Leave a Comment

Expion Health and Cost Plus Drugs Partner to Combat Soaring Specialty Drug Costs


Read More

GoodRx and Surescripts Brings Real-Time Drug Discount Pricing in EHRs

by Jasmine Pennic 08/05/2021 Leave a Comment

GoodRx and Surescripts Brings Real-Time Drug Discount Pricing in EHRs

What You Should Know: - Today, GoodRx announced an exclusive agreement with health information network Surescripts to deliver real-time drug discount price information for prescriptions in Surescript’ price transparency solution. - Surescripts is a nationwide network that connects virtually all EHRs, pharmacies and health systems, enabling providers to view patient-specific benefit and cost information and then electronically prescribe a medication. Last year, nearly 2 billion electronic
Read More

Capital Rx Launches Clearinghouse Model to Bring Price Visibility to Prescription Drug Costs

by Fred Pennic 09/04/2019 Leave a Comment

Capital Rx Brings Price Visibility to Prescription Drug Costs With The Launch of Industry First Clearinghouse Model

Quick Glance- Capital Rx launches new innovative Clearinghouse Model, a new pricing framework that will itemize the actual unit cost for all drugs for the first time- The Clearinghouse Model will eliminate price variability for customers, ensuring that drug costs are the same for all customers.- Pharmacies in its retail network, which includes chains, like Walmart, Walgreens, to grocers and independent pharmacies, will be able to deliver the lowest prescription prices to customers.- While rising
Read More

Capital Rx Lands $12M To Redefine The $550B Pharmacy Benefit Industry

by Jasmine Pennic 07/16/2019 Leave a Comment

Capital Rx Lands $12M To Redefine The $550B Pharmacy Benefit Industry

Capital Rx, a New York-based pharmacy benefits manager overseeing prescription benefit plans for employers, unions, and government entities, today announced it has raised $12M in growth funding led by Edison Partners.Transforming An Outdated Model“Historically, the PBM industry chose consolidation over innovation, which is why the model hasn’t evolved in twenty years,” said AJ Loiacono, founder, and CEO of Capital Rx. “The sad truth is employers procure office supplies more effectively than
Read More

Truepill Nabs $13.4M for B2B Pharmacy API and Fulfillment Service

by Fred Pennic 03/12/2019 Leave a Comment

  Truepill, a San Mateo, CA-based B2B pharmacy fulfillment service announced it has raised $13.4 million in Series A funding led by Initialized Capital, with participation from Y Combinator, Sound Ventures, Tuesday Capital and others. The company plans to utilize the funding to expand its team and fulfillment facilities across the US and enter the UK market. Why Truepill? As healthcare undergoes a massive shift towards telemedicine and direct-to-consumer care and treatment, Truepill is the
Read More

Drug Pricing Transparency: Can Health IT Lower Drug Pricing for Patients?

by Tom Borzilleri, CEO at InteliSys Health 05/24/2018 Leave a Comment

Drug Pricing Transparency: Can Health IT Lower Drug Pricing for Patients?

Certain practices of pharmacy benefit managers (PBMs) have helped jack up drug prices to the point where many people can no longer afford their medications. For example, PBMs charge health plans considerably more for a drug than they pay pharmacies for the same medication. This “ingredient spread,” which generates much of the PBMs’ profits, results in health plans placing drugs into a higher-price tier. As a result, members’ copayments go up. Sometimes they’re higher than the cash prices for
Read More

Truveris Raises $25M for Data-Driven Platform to Transform Prescription Benefits Ecosystem

by Fred Pennic 09/06/2017 Leave a Comment

Truveris Raises $25M for Data-Driven Platform to Transform Prescription Benefits Ecosystem

Truveris, a provider of cloud-based data analytics solutions for the prescription benefits industry has raised $25 million in Series D funding led by McKesson Ventures, and included Canaan Partners, New Leaf Venture Partners, Tribeca Venture Partners, and New Atlantic Ventures. The company plans to use the latest round of funding  to advance the company’s data and insights capabilities, which help manage rising prescription drug costs.Founded in 2009, Truveris aggregates data and insights from
Read More

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |